Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China

NCT07135986 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1602

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Infection
Healthy Volunteers

Interventions

BIOLOGICAL: MenACYW conjugate vaccine
BIOLOGICAL: MenACYW135 polysaccharide vaccine
BIOLOGICAL: MenAC conjugate vaccine

Sponsor

Sanofi